Why I’d Never buy NFTs

NFTs are very illiquid but stocks like HIVE Blockchain Technologies (TSXV:HIVE) are easy to invest in.

| More on:

Non-Fungible Tokens (NFTs) are all the rage these days.

Getting endless mentions on Twitter and other social platforms, they have taken the world by storm.

For the uninitiated:

NFTs are the latest product of the blockchain universe. They are digital assets bought and sold on blockchains just like cryptocurrencies. They signify ownership in digital assets like images and Tweets. Ownership of an NFT doesn’t give you exclusive access to the asset the NFT signifies ownership of. However, it does give you a unique claim on the asset’s digital signature that nobody else in the world has.

Over the past year, we have seen NFTs sell for some extreme prices. Jack Dorsey’s NFT of his first-ever Tweet sold for $2.5 million; since then, other million-dollar NFTs have been sold, including one that went for $69.3 million.

These extreme prices being paid for NFTs have predictably set off a speculative frenzy. People on Twitter and other social platforms are creating and selling NFTs at a furious pace, trying to net one of the big million-dollar paydays. Some are also buying up NFTs trying to sell them to others at higher prices. It’s an interesting idea, but I’d never personally buy into this trend. Here’s why.

NFTs are illiquid

The big problem with NFTs is that they aren’t liquid. You can’t just go on Coinbase and click “sell” and expect your NFT to sell. You have to actually find another individual who wants to buy it. Sure, there are platforms like OpenSea that allow you to buy and sell NFTs. But you have to hope that your auction goes well in order to turn a profit on an NFT. If nobody wants to buy it, your NFT will net you no profit.

Most big sales are from people with clout

Another problem with NFTs is that you realistically need a large social media following to make big money selling them. Most NFTs that fetched huge sums of money have been associated with famous people like:

  • Jack Dorsey
  • Grimes.
  • CryptoPunks
  • Mike “Beepel” Winklemann.

All of these individuals and organizations are very well known with large social media followings. So it shouldn’t come as a surprise that they were able to sell NFTs for millions. They have audiences of millions to sell to, and some of the richest among their audience members are billionaires. This isn’t an advantage that just anybody has. If you aren’t a celebrity yourself, it would be unreasonable to think that you can replicate it.

What about crypto?

Having established that I would never invest in NFTs, it’s time to talk about the closest asset that I would invest in:

Cryptocurrency.

I don’t own any crypto, but I’m not opposed to owning it in principle. If you look at the uses crypto is seeing in real- world businesses, in countries experiencing severe inflation, and elsewhere, it’s pretty clear that crypto is legit. So I’d probably buy some if I didn’t have stocks I was more interested in.

Another investment to consider is crypto mining stocks like HIVE Blockchain Technologies (TSXV:HIVE)(NASDAQ:HVBT). These are stocks that let you play crypto on the stock market. They mine and sell crypto for profit, rendering them effectively crypto pure-plays. In HIVE’s case, the currencies it mines are BTC and ETH, so its stock is like a bet on those coins. HIVE reportedly uses cold-climate data centres to reduce the cost of mining crypto.

Normally, crypto uses a lot of electricity. Part of that electricity cost is the cost of cooling the physical servers crypto is mined on. By housing its servers in places like Iceland and Sweden, HIVE aims to keep those costs to a minimum. Perhaps it’s one stock market play that crypto aficionados could consider if they wanted something more novel than crypto that’s less of a longshot than NFTs.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Twitter.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »